🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical drug-drug interaction study is being conducted to evaluate th...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00542893
This study is designed to evaluate the safety, efficacy, pharmacokinetics, ...
Status
Unknown
Location
New York University Cancer Center
Start Date
2006-11
Trial ID
NCT00409383
To characterize the pharmacokinetics of G3139 in subjects with normal, mild...
Status
Completed
Location
DaVita Clinical Research
Start Date
2006-05
Trial ID
NCT00543075
Treatments Being Tested
The treatment combination of Rituxan® (rituximab) and fludarabine has previ...
Status
Completed
Location
Georgetown University Medical Center/Lombardi Cancer Center
Start Date
2003-11
Trial ID
NCT00078234
Treatments Being Tested
To compare the efficacy and safety of combination treatment with Genasense,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00517218
Treatments Being Tested
Phase II trial to study the effectiveness of combining oblimersen with imat...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2002-11
Trial ID
NCT00049192
Treatments Being Tested
This is an open-label, parallel-group study with a total of 16 evaluable su...
Status
Terminated
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00543205
Treatments Being Tested